Longboard Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is September - August.

Millions USD. Fiscal year is Sep - Aug.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	May '25 May 10, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 26, 2023	Aug '22 Aug 27, 2022	Aug '21 Aug 28, 2021	Aug '20 Aug 29, 2020	2016 - 2020
Revenue	18,901	18,490	17,457	16,252	14,630	12,632	Upgrade
Revenue Growth (YoY)	5.15%	5.92%	7.41%	11.09%	15.81%	6.48%	Upgrade
Cost of Revenue	8,894	8,673	8,387	7,780	6,912	5,861	Upgrade
Gross Profit	10,008	9,817	9,070	8,473	7,718	6,771	Upgrade
Selling, General & Admin	6,297	6,028	5,596	5,202	4,730	4,269	Upgrade
Operating Expenses	6,297	6,028	5,596	5,202	4,730	4,269	Upgrade
Operating Income	3,711	3,789	3,474	3,271	2,988	2,502	Upgrade
Interest Expense	-492.2	-462.89	-318.43	-197.69	-200.75	-206.85	Upgrade
Interest & Investment Income	11.31	11.31	12.05	6.05	5.42	5.69	Upgrade
EBT Excluding Unusual Items	3,230	3,337	3,168	3,079	2,792	2,300	Upgrade
Other Unusual Items	-	-	-	-	-43	-83.9	Upgrade
Pretax Income	3,230	3,337	3,168	3,079	2,749	2,217	Upgrade
Income Tax Expense	666.38	674.7	639.19	649.49	578.88	483.54	Upgrade
Net Income	2,564	2,662	2,528	2,430	2,170	1,733	Upgrade
Net Income to Common	2,564	2,662	2,528	2,430	2,170	1,733	Upgrade
Net Income Growth	-2.34%	5.30%	4.07%	11.95%	25.24%	7.16%	Upgrade
Shares Outstanding (Basic)	17	17	19	20	22	24	Upgrade
Shares Outstanding (Diluted)	17	18	19	21	23	24	Upgrade
Shares Change (YoY)	-4.23%	-6.80%	-7.86%	-9.06%	-5.37%	-5.51%	Upgrade
EPS (Basic)	152.18	153.82	136.60	120.83	97.60	73.62	Upgrade
EPS (Diluted)	148.15	149.55	132.36	117.19	95.19	71.93	Upgrade
EPS Growth	1.97%	12.99%	12.95%	23.11%	32.34%	13.40%	Upgrade
Free Cash Flow	2,002	1,931	2,144	2,539	2,897	2,262	Upgrade
Free Cash Flow Per Share	115.73	108.49	112.24	122.45	127.06	93.90	Upgrade
Gross Margin	52.95%	53.09%	51.96%	52.13%	52.75%	53.60%	Upgrade
Operating Margin	19.63%	20.49%	19.90%	20.13%	20.42%	19.80%	Upgrade
Profit Margin	13.56%	14.40%	14.48%	14.95%	14.84%	13.72%	Upgrade
Free Cash Flow Margin	10.59%	10.45%	12.28%	15.62%	19.80%	17.91%	Upgrade
EBITDA	4,302	4,338	3,972	3,713	3,395	2,899	Upgrade
EBITDA Margin	22.76%	23.46%	22.75%	22.85%	23.21%	22.95%	Upgrade
D&A For EBITDA	591.13	549.76	497.58	442.22	407.68	397.47	Upgrade
EBIT	3,711	3,789	3,474	3,271	2,988	2,502	Upgrade
EBIT Margin	19.63%	20.49%	19.90%	20.13%	20.42%	19.80%	Upgrade
Effective Tax Rate	20.63%	20.22%	20.18%	21.09%	21.06%	21.82%	Upgrade
Advertising Expenses	-	102.7	99.5	97.1	85.9	77.6	Upgrade

Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q